267 related articles for article (PubMed ID: 22045183)
1. TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome.
Journe F; Id Boufker H; Van Kempen L; Galibert MD; Wiedig M; Salès F; Theunis A; Nonclercq D; Frau A; Laurent G; Awada A; Ghanem G
Br J Cancer; 2011 Nov; 105(11):1726-32. PubMed ID: 22045183
[TBL] [Abstract][Full Text] [Related]
2. Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients.
El Hajj P; Journe F; Wiedig M; Laios I; Salès F; Galibert MD; Van Kempen LC; Spatz A; Badran B; Larsimont D; Awada A; Ghanem G
Br J Cancer; 2013 Apr; 108(8):1641-7. PubMed ID: 23519055
[TBL] [Abstract][Full Text] [Related]
3. SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.
El Hajj P; Gilot D; Migault M; Theunis A; van Kempen LC; Salés F; Fayyad-Kazan H; Badran B; Larsimont D; Awada A; Bachelot L; Galibert MD; Ghanem G; Journe F
Br J Cancer; 2015 Jun; 113(1):91-8. PubMed ID: 26068396
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
5. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
6. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.
Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA
Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828
[TBL] [Abstract][Full Text] [Related]
7. Molecular staging of malignant melanoma: correlation with clinical outcome.
Shivers SC; Wang X; Li W; Joseph E; Messina J; Glass LF; DeConti R; Cruse CW; Berman C; Fenske NA; Lyman GH; Reintgen DS
JAMA; 1998 Oct; 280(16):1410-5. PubMed ID: 9801000
[TBL] [Abstract][Full Text] [Related]
8. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
[TBL] [Abstract][Full Text] [Related]
9. High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanoma.
Falkenius J; Lundeberg J; Johansson H; Tuominen R; Frostvik-Stolt M; Hansson J; Egyhazi Brage S
Melanoma Res; 2013 Dec; 23(6):452-60. PubMed ID: 24128789
[TBL] [Abstract][Full Text] [Related]
10. TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAF
Hartman ML; Czyz M
Arch Dermatol Res; 2020 Jul; 312(5):385-392. PubMed ID: 31624899
[TBL] [Abstract][Full Text] [Related]
11. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
[TBL] [Abstract][Full Text] [Related]
13. Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome.
Romanini A; Manca G; Pellegrino D; Murr R; Sarti S; Bianchi F; Alsharif A; Orlandini C; Zucchi V; Castagna M; Gandini D; Salimbeni G; Ghiara F; Barachini P; Mariani G
Ann Oncol; 2005 Nov; 16(11):1832-40. PubMed ID: 16107497
[TBL] [Abstract][Full Text] [Related]
14. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
Bieligk SC; Ghossein R; Bhattacharya S; Coit DG
Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS
J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625
[TBL] [Abstract][Full Text] [Related]
16. Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome.
Franco R; Cantile M; Scala S; Catalano E; Cerrone M; Scognamiglio G; Pinto A; Chiofalo MG; Caracò C; Anniciello AM; Abbruzzese A; Caraglia M; Botti G
Cancer Biol Ther; 2010 Mar; 9(6):423-9. PubMed ID: 20061818
[TBL] [Abstract][Full Text] [Related]
17. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
Martin G; Halwani F; Shibata H; Meterissian S
Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
Goydos JS; Gorski DH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
[TBL] [Abstract][Full Text] [Related]
19. No correlation of tyrosinase mRNA in bone marrow with prognosis of metastatic melanoma.
Waldmann V; Wacker J; Deichmann M; Näher H
Dermatology; 2000; 201(1):6-9. PubMed ID: 10971051
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
